Finoriq research workspace
Schrodinger, Inc. (SDGR) News
Schrödinger, Inc. develops physics-based computational platform that enables discovery of novel. Review SDGR recent headlines, source links, and company news on Finoriq.
Company Snapshot
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
- Company
- Schrodinger, Inc. (SDGR)
- Ticker
- SDGR
- Market Cap
- $1.1B
- Latest Price
- $15.19
- Industry
- Biotech & Pharma
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.